UBC faculty of medicine researchers received $11.1 million for two new projects to advance mRNA vaccine technologies and boost the impact of B.C. biotechnology on the global stage. By working alongside one another, the projects will demonstrate how collaboration can enhance benefits. Dr. Foster was quoted in the UBC Faculty of Medicine’s announcement (linked below) as stating “This funding builds off many years of collaboration between UBC and local biotech companies and will enable us to continue developing and refining vaccines, drugs, and biologics.”
Projects:
- Dr. Natalie Strynadka is Principal Investigator for the project “Grow B.C. biotech by advancing in-vitro and in-situ antiviral therapy for SARS-CoV2 variants” which received $7,680,000 in funding.
- Dr. Leonard Foster is the Principal Investigator for the project “Improve the delivery technology behind mRNA vaccines and other nanomedicines” which received $3,500,000 in funding.
Read more about the joint effort and impact of these projects here